Biogen discussed pilots in which they used an AI-enabled software to detect cognitive impairment and Alzheimer’s disease neuropathology, based on voice, to identify potential patients and reduce the burden of pre-screening.
Lead Podcast

Biogen discussed pilots in which they used an AI-enabled software to detect cognitive impairment and Alzheimer’s disease neuropathology, based on voice, to identify potential patients and reduce the burden of pre-screening.